Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 5Therapeutics 2Surveys and Questionnaires 2Cetuximab 2temsirolimus 1Tumor Burden 1Spectrum Analysis, Raman 1Risedronic Acid 1Raloxifene Hydrochloride 1Radiotherapy, Intensity-Modulated 1Radiomics 1Radiation, Ionizing 1Quality of Life 1Phlebotomy 1Neck Dissection 1Mohs Surgery 1Microscopy, Confocal 1Interviews as Topic 1Immunotherapy 1Ibandronic Acid 1Histocompatibility Testing 1Etidronic Acid 1Esophagectomy 1Dermoscopy 1Carboxylesterase 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Squamous Cell × Ibandronic Acid × Clear all
NCT01077817 2022-02-03

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Organon and Co

Completed
684,815 enrolled 6 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡